Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Povetacicept in Adults With Immunoglobulin A Nephropathy (RAINIER)

NCT06564142 is registered in ClinicalTrials.gov with Alpine Immune Sciences Inc, A Subsidiary of Vertex as lead sponsor.

NCT NCT06564142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06564142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Povetacicept in Adults With Immunoglobulin A Nephropathy (RAINIER)
Lead sponsor
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase
Phase 3
Overall status
Active, not recruiting
Start date
August 30, 2024
Completion date
January 30, 2028
Enrollment
605 (actual)
Sites
318

Conditions

As the registry lists them; a condition with its own page is linked.

immunoglobulin a nephropathy